You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

HALDRONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Haldrone, and when can generic versions of Haldrone launch?

Haldrone is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HALDRONE is paramethasone acetate. There are two drug master file entries for this compound. Additional details are available on the paramethasone acetate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HALDRONE?
  • What are the global sales for HALDRONE?
  • What is Average Wholesale Price for HALDRONE?
Drug patent expirations by year for HALDRONE

US Patents and Regulatory Information for HALDRONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-006 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for HALDRONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-005 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-006 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for HALDRONE

See the table below for patents covering HALDRONE around the world.

Country Patent Number Title Estimated Expiration
United Kingdom 902293 ⤷  Sign Up
Switzerland 378881 Verfahren zur Herstellung von Steroidverbindungen ⤷  Sign Up
United Kingdom 902292 ⤷  Sign Up
United Kingdom 902294 ⤷  Sign Up
Germany 1239307 Verfahren zur Herstellung therapeutisch wirksamer Steroidverbindungen ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.